(NASDAQ: NSTG) Nanostring Technologies's forecast annual revenue growth rate of 13.71% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 5.58%, and it is also forecast to beat the US market's average forecast revenue growth rate of 6.46%.
Nanostring Technologies's revenue in 2023 is $162,473,000.On average, 3 Wall Street analysts forecast NSTG's revenue for 2023 to be $8,556,252,818, with the lowest NSTG revenue forecast at $8,546,773,512, and the highest NSTG revenue forecast at $8,565,058,468. On average, 3 Wall Street analysts forecast NSTG's revenue for 2024 to be $9,875,368,059, with the lowest NSTG revenue forecast at $9,715,085,981, and the highest NSTG revenue forecast at $10,076,646,933.
In 2025, NSTG is forecast to generate $11,954,560,061 in revenue, with the lowest revenue forecast at $11,730,280,637 and the highest revenue forecast at $12,178,887,604.